



An experimental pharmaceutical might one day circumvent the body's cold-defense mechanisms to protect tissue following stroke, heart attack and problems at birth
By Gary Stix | Feb 15, 2012
Certain kinds of physical and emotional pain share a neural pathway that responds to acetaminophen
The U.S. Food and Drug Administration prepares to weigh the safety and efficacy of new flab fighters
By Erica Westly | Sep 14, 2010 | 5
Hailed as a potential alternative to embryonic stem cells, induced pluripotent stem cells (iPS cells) raise their own ethical dilemmas
By Sally Lehrman | Sep 13, 2010 | 28
Impact-delivered graphite discovered in Apollo moon rock
By John Matson | Sep 9, 2010
Demonstration that an atom can control the passage of light could be crucial in quantum computing and communications
By Davide Castelvecchi | Sep 8, 2010 | 10
To unify the four forces of nature, physicists are turning to Lie groups, an approach famously resurrected in 2007 by a surfer-dude theorist
By Zeeya Merali | Sep 7, 2010 | 55
Several headline-grabbing accidents have shone light on chronically poor safety records
By Beryl Lieff Benderly | Aug 17, 2010 | 16
The ability to make cells with artificial genomes bodes well for basic biology
By David Biello and Katherine Harmon | Aug 12, 2010 | 1
New understanding of epigenetics, or the molecular processes that control genes, show how it underlies hereditary forms of obesity and cancer
As the electric car market expands, Sandia National Laboratories' battery-abuse testing facility gets a workout
By Mark Fischetti | Aug 5, 2010 | 4
Acid rain is back—this time triggered by nitrogen emissions
By Michael Tennesen | Aug 1, 2010 | 1
By John Matson | Aug 1, 2010 | 3
Attempt to resolve toxicity issue of oil dispersants muddies the water
By David Biello | Aug 1, 2010 | 3
A radically simpler design avoids the standard p-n semiconductor junctions
By Davide Castelvecchi | Jul 20, 2010 | 10
New concerns about customer reviews on Web sites
By Michael Moyer | Jul 19, 2010 | 22
Proton-pump inhibitors such as Nexium, Prevacid and Protonix treat acid reflux, but their use as a preventative to bleeding can lead to problems
By Melinda Wenner Moyer | Jul 15, 2010 | 4
New sleep aids block the activity of brain peptides called orexins, which play a role in addiction
By Christine Soares | Jul 1, 2010 | 2
By John Matson | Jul 1, 2010
A long and pronounced solar minimum befuddles astronomers
By John Matson | Jul 1, 2010 | 6
Your Web-enabled mechanical stunt double is ready
By Larry Greenemeier | Jul 1, 2010 | 1
By Ferris Jabr | Jul 1, 2010
The job of cleaning up after the Gulf oil spill will fall to the microbes
By David Biello | Jul 1, 2010 | 1
False claims still pervade the supplements industry
By Katherine Harmon | Jul 1, 2010
Traffic avoided: Software uses road sensors, GPS and historical traffic data to predict congestion
By Mark Fischetti | Jun 10, 2010 | 3
See what we're tweeting about
DrBondar Oooooooh look what just arrived in the mail! @laelaps new book!! Woot! http://t.co/yVUngMH0f8
JenLucPiquant Why Rational People Buy Into Conspiracy Theories http://t.co/4okVWUldzA
sciam What unconventional fuels tell us about the global energy system http://t.co/YGr6z4X9Y9
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.